TLR4 and neoplasm: Meanwhile, butyrate can enhance nuclear factor kappa B (NF‐κB) signalling activation mediated by Toll‐like receptor 4 (TLR4) in colon cancer cells, thereby strengthening anti‐tumour innate immunity.11